Lee Sang Geun, Ryu Hwa Jung, Kim Il-Hwan
Department of Dermatology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
Ann Dermatol. 2014 Dec;26(6):755-7. doi: 10.5021/ad.2014.26.6.755. Epub 2014 Nov 26.
Many treatment modalities have been developed for axillary osmidrosis. It is well known that the surgical treatment has the best results. However, there is a high possibility of side effects. The 1,444-nm lipolysis laser has been recently introduced to remove the apocrine glands. So far, subdermal coagulation treatment with a 1,444-nm Nd:YAG laser may be the least invasive and most effective therapy for axillary osmidrosis. However, according to our previous experience, the recurrence rate was 20%~30%. This emphasizes the need for combination of surgical method and non-surgical method and we combined subcutaneous tissue removal and photothermocoagulation with a 1,444-nm Nd:YAG laser. Three patients for bilateral axillary osmidrosis were enrolled. After an incision of about one-third the length of the widest transverse diameter, the apocrine glands were separated from the skin. And then apocrine glands within the marked area were destroyed by irradiation with a 1,444-nm Nd:YAG laser thereafter. All patients exhibited no relapse of axillary osmidrosis and were satisfied with the treatment results. A combination of subcutaneous tissue removal and Interstitial laser photothermocoagulation with a 1,444-nm Nd:YAG laser could be an effective treatment for mild to moderate axillary osmidrosis.
针对腋臭已经开发出多种治疗方式。众所周知，手术治疗效果最佳。然而，副作用的可能性很高。1444纳米脂肪分解激光最近已被用于去除顶泌汗腺。到目前为止，用1444纳米钕:钇铝石榴石激光进行皮下凝固治疗可能是治疗腋臭侵入性最小且最有效的方法。然而，根据我们之前的经验，复发率为20%至30%。这强调了手术方法与非手术方法结合的必要性，我们将皮下组织切除与1444纳米钕:钇铝石榴石激光光热凝固相结合。招募了3例双侧腋臭患者。在进行约为最宽横径长度三分之一的切口后，将顶泌汗腺与皮肤分离。然后用1444纳米钕:钇铝石榴石激光照射破坏标记区域内的顶泌汗腺。所有患者的腋臭均未复发，对治疗结果满意。皮下组织切除与1444纳米钕:钇铝石榴石激光间质激光光热凝固相结合可能是治疗轻至中度腋臭的有效方法。
